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тивная операция на экстракраниальных артериях, второй 
этап - спустя 4-6 суток после первого хирургического вме-
шательства – реваскуляризция аорто-подвздошно-бедрен-
ной артериальной зоны или обоих артериальных бассейнов 
одномоментно.
reziume
eqstrakraniuli arteriebis da aortul-TeZosqve-
Sa-barZayis segmentis Serwymuli okluziur-
stenozuri dazianebis qirurgiuli mkurnaloba 
reperfuziul-reoqsigenaciuri garTulebebis 
ganviTarebis maRali riskis pirobebSi
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kvlevis mizans warmoadgenda eqstrakraniuli 
arteriebis da aortul-TeZosqveSa-barZayis seg-
mentis Serwymuli okluziur-stenozuri da-
zianebis qirurgiuli mkurnalobis Sedegebis 
gaumjobeseba reperfuziul-reoqsigenaciuri 
garTulebebis ganviTarebis maRali riskis piro-
bebSi.
gamokvleulia 58 pacienti eqstrakraniuli ar-
teriebis da aortul-TeZosqveSa-barZayis segmen-
tis Serwymuli aTerosklerozuli dazianebiT. 
arteriuli nakadis dazianebis xasiaTis da he-
modinamikuri darRvevebis Taviseburebebis dia-
gnostikisaTvis gamoynebulia ultrabgeriTi 
doplerografgia, dupleqsuri skanireba, ren-
tgenokontrastuli cifruli angiografia. wi-
nasaopercio mzadebis sistemaSi reperfuziul-
reoqsigenaciuri garTulebebis ganviTarebis 
profilaqtikisaTvs gamoyenebulia SeTavazebul 
RonisZiebaTa kompleqsi. 
eqstrakraniuli arteriebis okluziur-steno-
zuri dazianebisa da kontrlateraluri SigniTa 
saZile arteriis stenozuri procesis Serwymis 
xSir gavrcelebasTan dakavSirebiT, Tavis tvi-
nis sisxlis mimoqcevis SedarebiTi kompensaciis 
stadiaze 7  pacients operacia Cautarda kisris 
sisxlZarRvebze. Ppirveli qirurgiuli Carevidan 
4-6 dRis Semdeg Catarda aortul-TeZosqveSa-bar-
Zayis segmentis revaskularizacia.
51 pacients Cautarda erTmomentiani qirurgi-
uli Careva eqstrakraniul arteriebsa da aor-
tul-TeZosqveSa-barZayis auzze.
orive arteriuli auzis revaskularizacia Catar-
da etapobrivad: pirveli etapi – rekonstruqci-
uli operacia eqstrakraniul arteriebze, meore 
etapi –pirveli qirurgiuli Carevidan 4-6 dRis 
Semdeg - aortul-TeZosqveSa-barZayis arteriuli 
zonis, an orive arteriuli auzis erTmomentiani 
revaskularizacia.
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Penetrating craniocerebral gunshot wounds (PCGW) are a 
threat to victims’ lives and long-term health, primarily due to 
the injury and resulting destruction of brain tissue as well as 
bacterial penetration of detritus into the cranial cavity and sub-
sequent risk of wound infection. Bacterial contamination is al-
ready known to occur in cases of soft tissue injuries of the head 
and increases considerably if a non-sterile injuring projectile 
penetrates the cranial cavity [6]. Following the injuring projec-
tile, fragments of skull, skin, hair, cranial bones, hot air, powder 
gases, etc., pierce through the brain, significantly increasing the 
risk of intracranial purulent-septic complications (PSCs) [1,18].
According to the U.S. military guidelines on the prevention of 
infections associated with combat-related injuries [8], cefazolin 
(2 g every 6-8 h) is prescribed as initial empiric antibiotic therapy 
(ABT) for PCGWs, and if wound contamination is significant, 
metronidazole (500 mg every 8–12 h) is added. Clindamycin 
(1,800–2,700 mg/day) or ceftriaxone (2-4 g/day) and metroni-
dazole (500 mg every 8-12 h) are considered to be therapeutic 
alternatives. In cases of penicillin allergy, vancomycin (2 g/day) 
and ciprofloxacin (400–800 mg/day) are recommended.
Intravenous antibiotics should be administered as soon as pos-
sible after the injury, preferably within 3 h. The antibiotic used 
should be sufficient to manage pathogenic microorganisms that 
can contaminate wounds during injury, including normal skin 
and intestinal flora, such as Staphylococcus, Escherichia coli 
and anaerobes of the gastrointestinal tract.
Initial antibacterial therapy should not target pathogens with 
multiple antibiotic resistance such as Acinetobacter baumannii, 
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Pseudomonas aeruginosa or Klebsiella pneumoniae. Because of 
decreased levels of methicillin-resistant Staphylococcus aureus 
infections and clinical evidence that adequate wound drainage, 
rather than antibiotics, is considered primary treatment in cases 
of abscesses, empiric therapy with vancomycin or linezolid may 
not be appropriate. Data have shown that empiric use of broad-
spectrum antibiotics can lead to subsequent antibiotic-resistant 
infections [10].
The duration of ABT should be reduced to a minimum. Stud-
ies have reported that long-term therapy diminishes the outcome 
[15]. Wounds should be cleaned thoroughly at each bandage 
change with 4% chlorhexidine gluconate. Treatment of gun-
shot wounds often involves delayed initial closure of extrem-
ity wounds. However, facial and cerebral injuries require early 
primary closure of mucous membranes or dura mater to reduce 
the incidence of infections and aesthetic complications [4,18].
Study objective - to analyse pathogens and their susceptibility 
to antibiotic therapy in combat-related penetrating craniocere-
bral gunshot wounds patients and establish recommendations 
for the treatment of post-traumatic meningoencephalitis.
Material and methods. One hundred twenty-one patients 
who were admitted to the Public Institution, Mechnikov Dni-
propetrovsk Regional Clinical Hospital, Dnipro, Ukraine, from 
25 May 2014, to 31 December 2017, were successively enrolled 
in the study. The main inclusion criterion was a combat-related 
PCGW. All wounds were sustained during the combat opera-
tions in the eastern Ukraine.
Penetrating craniocerebral wounds (PCWs) are injuries that 
damage the integrity of the dura mater, which can lead to bacterial 
penetration into the skull. Clinical symptoms of PCWs include dis-
charge of cerebrospinal fluid (CSF) and/or brain fragments from the 
wound. Symptoms of a penetrating craniocerebral wound on head 
and neck computed tomography include intradural or intracerebral 
foreign bodies and pneumocephalus [17].
ABT was administered according to the guidelines for the 
treatment of combat-related injuries [8]. Empirical ABT lasted 
for up to 5 days. Antibacterial therapy was adjusted according 
to results of bacteriological examination, and its efficacy was 
based on procalcitonin, a generally recognised marker for sep-
sis. Microbiological studies were performed in a clinicodiag-
nostic laboratory with a bacteriological analyser, VITEK 2 (bio-
Mérieux., Inc., France). We were able to identify the pathogen 
and prescribe targeted ABT (etiotropic treatment) in most cases 
of PSCs.
Results and their discussion. The study included 121 male 
patients aged 18 to 56 years (mean, 34.1±9.1). The Glasgow 
Coma Scale score ranged from 3 to 15 (mean, 10±4), and the 
Injury Severity Score ranged from 16 to 57 (mean, 27.7±7.6). 
Overall, 101 patients (83.5%) were diagnosed with shrapnel 
wounds and 20 (16.5%) with gunshot wounds.
The characteristics of microorganisms extracted during mi-
crobiological study of patients with PSCs are shown in Table 1.
Bacteriological examination of patients with PSCs due to pen-
etrating CGSWs revealed that Acinetobacter baumannii, one of 
the most important representatives of so-called hospital flora, 
caused the highest incidence of infections, including post-trau-
matic meningitis. A. baumannii typically involves the skin and 
respiratory tract but can also cause other infections due to trans-
location, including those related to past medical procedures.
The most notable characteristic of this microorganism is its 
high pathogenicity in hospital patients who have been seriously 
ill for an extended period, including those with a weakened im-
mune system. Patients with invasive medical devices, such as 
vascular and other catheters, surgical sutures or respiratory ven-
tilators, and those who have received renal replacement therapy 
(haemodialysis) or antimicrobial therapy for the last 90 days are 
also at risk of developing A. baumannii infections.
Data on the relationship between the high incidence of this patho-
gen in patients with combat-related gunshot wounds have been re-
ported. A. baumannii became particularly well known during the 
U.S. Army›s military operations in Iraq during Operation Iraqi 
Freedom, causing an increased incidence of bloodstream infections 
among U.S. military personnel, called Iraqibacter [9].
A. baumannii is more likely to affect moist tissues, such as 
mucous membranes or damaged skin areas, where it may cause 
necrotising infection. Areas of infection or colonisation may 
involve the respiratory tract, blood, pleural fluid, urinary tract, 
surgical wounds, central nervous system (CNS), skin and eyes. 
Pneumonia can pose a threat to patients requiring mechanical 
ventilation, as A. baumannii has the ability to produce biofilms 
on endotracheal tube surfaces. A study conducted in 2003 on 
board the U.S. Navy hospital ship Comfort, which provided 
Table 1. Results of bacteriological examinations
Microorganism
Infection location 
CSF Wound infection Respiratory tract infection
Urinary tract 
infection TOTAL
Acinetobacter baumannii 5 1 5 0 11
Klebsiella pneumoniae 2 1 4 0 7
Escherichia coli 0 1 1 0 2
Pseudomonas aeruginosa 1 2 5 0 8
Staphylococcus aureus 0 0 1 0 1
Staphylococcus epidermidis 2 0 0 0 2
Staphylococcus haemolyticus 0 0 3 0 3
Enterobacter agglomerans 1 0 2 0 3
Enterococcus faecalis 1 1 0 0 2
Enterococcus faecium 0 0 1 0 1
Candida 0 0 0 1 1
TOTAL 12 6 22 1 41
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emergency medical care to injured U.S. military personnel in 
the Persian Gulf, showed that 4.1% of all skin and soft tissue 
infections were associated with A. baumannii [5].
The incidence of A. baumannii infections is increasing, es-
pecially in the U.K. and the U.S., as coalition forces exposed 
to bacteria in field hospitals return home to recover and reha-
bilitate.
Together with the development of skin, soft tissue, respiratory 
tract and bloodstream infections due to A. baumannii, neuro-
surgical patients are reported to have worsening of nosocomial 
post-surgical meningitis, which is a serious problem in those un-
dergoing intensive therapy [3,12].
The second most common pathogen in our patients was Pseu-
domonas aeruginosa, which is also characteristic of hospital-
acquired postoperative wound, respiratory tract and bloodstream 
infections in patients with a weakened immune system and those 
requiring invasive medical devices.
The efficacy of infection control measures, particularly hand 
hygiene and disinfection of the surrounding area, plays a major 
role in the spread of P. aeruginosa. Antibiotic-resistant Pseu-
domonas can be fatal in critically ill patients. In total, 51,000 
medically related P. aeruginosa infections are estimated to oc-
cur each year in the United States. More than 6,000 (13%) cases 
have multiple drug resistance, with approximately 400 deaths 
associated with these infections per year [2].
Meningitis and ventriculitis caused by P. aeruginosa are pri-
marily nosocomial infections and are related to previous neuro-
surgical procedures. Statistics have shown that P. aeruginosa is 
responsible for 1%–18% of cases of nosocomial meningitis [14].
K. pneumoniae was the third most common pathogen with 
infectious complications in our patients. In cases of K. pneu-
moniae, meningitis is most often considered a hospital-acquired 
infection related to neurosurgery and is associated with high 
mortality, despite the wide availability of antimicrobial and ad-
junctive therapies, due to its abnormal characteristics and the 
difficulty in detecting it at an early stage. Clinical outcomes of 
K. pneumoniae meningitis are often unsatisfactory. Studies have 
reported higher rates of diabetes, alcoholism and chronic liver 
diseases in addition to pre-existing infections (such as pyogenic 
liver abscess, septic endophthalmitis, pneumonia, otitis media, 
urinary tract infection, lumbar discitis and perianal abscess) in 
patients with K. pneumoniae meningitis who had undergone 
neurosurgical procedures [11].
Staphylococcus epidermidis are typically in hospital infec-
tions associated with the use of intravenous catheters and per-
manent prostheses. Colonisation of S. epidermidis on the skin 
of patients and health care workers is considered the most 
common source of these infections. This pathogen’s ability 
to stick and form biofilms on the surfaces of foreign bodies 
is considered to be its most important mechanism. S. epider-
midis meningitis is typically associated with neurosurgical 
procedures and devices, such as ventriculoperitoneal shunts, 
as well as head injury [13].
Meningitis caused by Enterobacter species rarely occurs in 
adults, although it may develop in neurosurgery patients and 
those sustaining neurotrauma. Treatment is often complicated 
because of the resistance of many Enterobacter isolates to 
third-generation cephalosporins and poor penetration of other 
antibiotics into the CNS. The most common pathogens are En-
terobacter cloacae, Enterobacter aerogenes and Enterobacter 
agglomerans (50%, 34% and 16% of cultures, respectively). 
Overall, 47% of patients had clinical recovery/improvement, 
whereas 21% died [7].
Enterococcus faecalis caused by meningitis is an uncommon 
disease accounting for <1% of all cases of adult meningitis. 
This infection typically affects patients with immune disorders 
or CNS injuries, primarily in the form of hospital-acquired in-
fections. It is also associated with neurosurgical procedures 
and shunting. The overall mortality rate was 21% in the pres-
ent study. Adverse outcomes largely correspond with old age, 
presence of serious underlying disease, associated enterococcal 
infection, bacteraemia, septic shock and absence of fever on ad-
mission [16].
Thus, our careful analysis of infectious complications of 
pathogens in patients with PCWs revealed that most cases are 
nosocomial infections. The most effective prevention strategy 
includes a modern infection control system focusing on barrier 
measures to prevent the spread of infection. Targeted ABT to-
ward the pathogen’s sensitivity to antibiotics and antiseptics is 
the preferred treatment strategy.
We performed a detailed analysis of the sensitivity of mi-
croorganisms extracted from biological tissues to antibacterial 
agents (Table 2).
Sensitivity analysis of microorganisms detected in our pa-
tients to antibiotics revealed that, in most cases, the efficacy of 
the first-line ABT (ACCESS) was low and it was often neces-
sary to prescribe broad-spectrum antibacterial drugs, including 
those related to second-line antibiotics (WATCH) and reserve 
drugs (RESERVE), according to the World Health Organisation 
classification [20].
Data in the literature confirm the results of our bacteriological 
studies.
Modern A. baumannii infections are characterised by multi-
drug resistance to antimicrobials and antiseptics. The MYSTIC 
study, performed in 48 European hospitals between 2002 and 
2004, reported that only 73.1% of A. baumannii isolates were 
susceptible to meropenem and 69.8% to imipenem. Susceptibil-
ity to other antibiotics was also extremely low: 32.4%, 34.0% 
and 47.6% were sensitive to ceftazidime, ciprofloxacin and 
gentamicin, respectively. Despite extensive administration of 
broad-spectrum ABT, the mortality rate in such infections can 
reach 70% [19].
The high resistance of P. aeruginosa infections requires treat-
ment with intravenous antibiotics such as ceftazidime, carbapen-
ems (meropenem and imipenem), aminoglycosides (gentamicin, 
amikacin or tobramycin) and ciprofloxacin, often in combina-
tion with intrathecal agents such as aminoglycosides or colistin. 
The recommended duration of therapy is from 14 to 28 days. In 
spite of this, treatment failures and relapses occur, with mortal-
ity reaching 80% [14].
For the treatment of K. pneumoniae infections in patients with 
CNS injury undergoing neurosurgical procedures, the primary 
component of survival, recovery and a favourable neurological 
outcome is early intravenous administration of first-line antibi-
otics before decline in neurological status (GCS≤7). Extended-
spectrum cephalosporins are typically the drugs of choice, but 
aztreonam, carbapenems, aminoglycosides and ciprofloxacin 
are also used with varying degrees of effectiveness. Expected 
therapy duration ranges from 14 to 21 days [11].
In the present study, intracranial PSCs were detected in 14 
(11.6%) patients. In addition, isolated meningoencephalitis oc-
curred in eight patients, meningoencephalitis combined with 
ventriculitis in three and meningoencephalitis combined with 
ventriculitis and subdural empyema in two. Recurrent menin-
goencephalitis was complicated by multiple brain abscesses in 
one patient.
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Table 2. Detected microorganism sensitivity to antibiotics
Microorganism
Sensitivity to antibiotics
CSF Wound infection Respiratory tract infection Urinary tract infection
Acinetobacter baumannii
Cefoperazone/sul-
bactam, Meropenem, 
Tigecycline, Tobra-
mycin
Tobramycin
Colistin, Tigecycline, Cefopera-
zone/sulbactam
-
Klebsiella pneumoniae
Amikacin, Piperacil-
lin/tazobactam, Tige-
cycline, meropenem
Tobramycin
Amikacin, Cefoperazone/sulbac-
tam, Meropenem, Gentamicin, 
Tobramycin, Trimethoprim/sul-
famethoxazole, Ciprofloxacin
-
Escherichia coli
-
-
Gentamicin, Amikacin, 
Meropenem, Tobramy-
cin, Ciprofloxacin
Meropenem, cefoperazone/sul-
bactam, Ceftriaxone
-
Pseudomonas aerugi-
nosa
-
Cefoperazone/sul-
bactam, Gentamicin, 
Amikacin, Merope-
nem, Ciprofloxacin, 
Colistin, Ceftazidime 
Cefoperazone, cefoperazone/sul-
bactam, Tigecycline, Tobramy-
cin, Colistin, Levomycetin
-
Staphylococcus aureus
-
-
Vancomycin, Ttigecycline, 
Gentamicin
-
Staphylococcus epider-
midis
Levofloxacin, 
Tigecycline, Trim-
ethoprim
- - -
Staphylococcus haemo-
lyticus
-
-
Levofloxacin, Tigecycline, 
Cefoperazone/sulbactam, 
Clindamycin
-
Enterobacter agglom-
erans
Amikacin, Merope-
nem
- Tigecycline, Meropenem -
Enterococcus faecalis 
Linezolid, Vanco-
mycin
-
Imipenem, Colistin, Cefopera-
zone/sulbactam, Tobramycin
-
Enterococcus faecium - - Amphotericin B, Caspofungin -
Candida - - -
Fluconazole, 
Voriconazole
Post-traumatic meningoencephalitis caused by S. еpidermidis 
is characteristically associated with neurosurgical procedures 
and devices, such as ventriculoperitoneal shunts, as well as head 
injury. Glycopeptides (vancomycin and teicoplanin) are usually 
effective for intensive therapy, and oxazolidinones (linezolid) 
are effective in treating methicillin-resistant strains [13].
Treatment of meningoencephalitis caused by Enterobacter 
family microorganisms is characterised by low resistance to 
third-generation cephalosporins. Successful therapy involves 
intravenous and intrathecal administration of aminoglyco-
sides, trimethoprim-sulfamethoxazole, piperacillin and cip-
rofloxacin [7].
Treatment of meningoencephalitis associated with Enterococ-
cus faecalis usually includes ampicillin, penicillin, vancomycin 
and linezolid, with or without aminoglycosides, for an average 
period of 18 days. Other effective agents are intrathecal genta-
micin and intravenous dexamethasone [16].
On the basis of the present study, we have formulated recom-
mendations for antibiotic treatment of post-traumatic meningo-
encephalitis in combat-related CGSWs (Table 3).
Thus, because of the high risk of multi-drug-resistant hos-
pital flora translocation, with clinical laboratory data indi-
cating development of post-traumatic meningoencephalitis, 
we started de-escalation of empiric ABT with the broadest-
spectrum drugs as monotherapy, and combination therapy 
was primarily used in cases of expected gram-positive and 
gram-negative aerobic and anaerobic pathogenic bacteria. 
Modification of empiric ABT was performed on the ba-
sis of clinical data regarding development of the infection 
process over time, SIRS markers, sepsis and multisystem 
failure. After receiving results of microbiological studies, 
targeted medication of ABT was initiated immediately, 
with a preference for etiotropic therapy and aggressive mi-
crobiological control.
Conclusions. Modern combat-related GSWs are serious in-
juries with numerous entry points for infection. Factors leading 
to immunosuppression in patients and promoting generalised 
infection of gunshot wounds include the presence of multiple 
primary wound infections, blood loss, anaemia, shock, malnutri-
tion and chronic stress.
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ABT for severe PSCs of PCGWs is effective when thoroughly 
and continuously controlled (daily or every 2–3 days) by bac-
teriological monitoring, a so-called monitoring-based antibiotic 
therapy.
Initial elimination of pathogens is often accompanied by 
superinfection development with ESKAPE pathogens (En-
terococcus faecium, Staphylococcus aureus, Klebsiella pneu-
moniae, Acinetobacter baumannii, Pseudomonas aeruginosa, 
Enterobacter species), and use of procalcitonin-guided ABT 
is recommended. Procalcitonin level <0.5 ng/mL is a sign to 
stop ABT.
It is reasonable to use combined ABT, combining drugs with 
different mechanisms of action, and it is acceptable to monitor 
the mode of dose- and time-dependent antibiotics administra-
tion.
In order to achieve minimum inhibitory (suppressive) concen-
tration of an antibacterial drug in cases of increased clearance, 
the maximum permitted dose of the drug should be used. In-
creased drug clearance may be due to increased renal blood flow, 
hypervolaemia, overhydration or hyperdynamic circulation.
Conclusions.
Regarding PSC pathogens: Our results showed that, in most 
cases, such infections are considered nosocomial and are related 
to invasive medical procedures and devices. The most effective 
strategy in their prevention is implementing a modern infection 
control system with an emphasis on barrier measures against the 
spread of infection. Targeted ABT with early identification of 
the pathogen and its sensitivity to antibiotics and antiseptics is 
the preferred treatment strategy.
Regarding AB sensitivity of PSC pathogens: Our results 
showed that the efficacy of first-line antibiotics (ACCESS) was 
typically low and it was often necessary to prescribe broad-spec-
trum antibiotics, including those related to second-line antibiot-
ics (WATCH) and reserve drugs (RESERVE), according to the 
WHO classification.
Regarding ABT of PSC: The use of initial de-escalation of em-
piric ABT using the broadest-spectrum drugs, mainly as a part of 
combination therapy for expected gram-positive and gram-neg-
ative aerobic and anaerobic infection pathogens, is recommend-
ed. Modification of empiric ABT is made on the basis of clinical 
Table 3. Post-traumatic meningoencephalitis ABT for craniocerebral gunshot wounds
ABT
MicroorganismEmpiric in escalation mode
De-escalation
Empiric de-esca-
lation modified 
(when there is no 
culture growth)
Targeted, ini-
tial (according 
to inoculation 
results)
Etiotropic-1
Targeted, 
modified for 
the 1st time 
(according to 
inoculation 
results)
Etiotropic-2
Targeted, modified 
for the 2nd time 
(according to in-
oculation results)
Etiotropic-2
Meropenem+metronidazole 
(3)
Meropenem-vancomycin (6)
Meropenem-colimycine (1)
Meropenem-ornidazole (1)
Meropenem-cefosulbin
Cefoperazone/sulbactam-
ertapenem,
Tienam-ornizol 
Cefoperazone/sul-
bactam,
Vancomycin-me-
ropenem,
Tienam-vancomy-
cin, Vancomycin-ti-
gecycline, Tigecy-
cline-piperacillin/
tazobactam-linezol-
id, Tigecycline-line-
zolid-colomycin,
Linezolid-colomycin
Tigecycline,
Levofloxacin-vanco-
mycin
Ceftriaxone/
sulbactam, 
Colomycin, 
Piperacillin/
tazobactam, 
Cefoperazone/
sulbactam, 
Tigecycline, 
Biseptol,
Tigecycline +Tigecycline, etc.
Acinetobacter 
baumannii
Tigecycline Gentamicin
Klebsiella pneu-
moniae
Meropenem (2) Escherichia coli
Tigecycline Chloramphenicol
Pseudomonas 
aeruginosa
Vancomycin
Staphylococcus 
aureus
Biseptol, vanco-
mycin
Tigecycline S. epidermidis
Tigecycline 
(2)
S. haemolyticus
Enterobacter 
agglomerans
Vancomycin Linezolid
Escherichia 
faecalis
Escherichia 
faecium
Fluconazole Candida
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data regarding development of the infectious process over time, 
SIRS markers, sepsis and multiple organ dysfunction. Targeted 
modification of ABT is performed immediately upon determin-
ing the results of microbiological studies, with a preference for 
etiotropic therapy and aggressive microbiological control.
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SUMMARY
ANTIBACTERIAL THERAPY FOR PURULENT-SEP-
TIC COMPLICATIONS IN PATIENTS WITH COMBAT 
RELATED PENETRATING CRANIOCEREBRAL GUN-
SHOT WOUNDS
1Sirko A., 1Yovenko I., 1Zhyliuk V., 
2Mosentsev M., 2Pilipenko G.
1State Establishment, Dnipropetrovsk Medical Academy, Min-
istry of Healthcare of Ukraine; 2Public Institution, Mechnikov 
Dnipropetrovsk Regional Clinical Hospital, Ukraine
Aim - to evaluate pathogens and their susceptibility to antibi-
otic therapy (ABT) in combat-related penetrating craniocerebral 
gunshot wound (PCGW) patients and develop recommendations 
for treatment of post-traumatic meningoencephalitis.
We conducted a prospective analysis of examination and 
treatment results of 121 patients who were admitted to the Pub-
lic Institution, Mechnikov Dnipropetrovsk Regional Clinical 
Hospital, Dnipro, Ukraine, from 25 May 2014, to 31 December 
2017, and were successively enrolled in the study. Intracranial 
purulent-septic complications were diagnosed in 14 (11.6%) 
patients including eight cases of isolated meningoencephalitis, 
three cases of meningoencephalitis combined with ventriculitis, 
two cases of meningoencephalitis combined with ventriculitis 
and subdural empyema and one case of multiple brain abscesses.
In most cases of combat-related craniocerebral wounds, infec-
tions are considered nosocomial and typically related to medi-
cal procedures and devices. In most cases, the effectiveness of 
first-line antibiotics was low, and it was often necessary to pre-
scribe broad-spectrum ABT, including those related to second-
line antibiotics and reserve drugs, according to the World Health 
Organisation classification. The use of initial de-escalation of 
empiric ABT with the broadest-spectrum drugs, mainly as a part 
of combination therapy for expected gram-positive and gram-
negative aerobic and anaerobic infection pathogens, is recom-
mended.
Keywords: purulent-septic complications, pathogens, sus-
ceptibility of pathogens, antibacterial therapy, penetrating cra-
niocerebral wounds, combat-related gunshot wounds.
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Цель исследования - анализ возбудителей инфекций и их 
чувствительности к антибактериальной терапии у пациен-
тов с боевыми огнестрельными проникающими черепно-
мозговыми ранениями; разработка рекомендаций по лече-
нию посттравматического менингоэнцефалита.
Проведен проспективный анализ результатов обследо-
вания и лечения 121 пациента с боевыми проникающими 
черепно-мозговыми ранениями. Пострадавшие поступи-
ли в Днепропетровскую областную клиническую боль-
ницу им. И.И. Мечникова в период с 25 мая 2014 г. по 
31 декабря 2017 г.  Внутричерепные гнойно-септические 
осложнения выявлены у 14 (11,6%) раненных: изолиро-
ванный менингоэнцефалит - 8 случаев, менингоэнцефа-
лит в сочетании с вентрикулитом – 3 случая, менинго-
энцефалит в сочетании с вентрикулитом и субдуральной 
эмпиемой – 2 случая, множественное абсцедирование 
РЕЗЮМЕ
АНТИБАКТЕРИАЛЬНАЯ ТЕРАПИЯ ГНОЙНО-СЕПТИЧЕСКИХ ОСЛОЖНЕНИЙ У ПАЦИЕНТОВ 
С БОЕВЫМИ ОГНЕСТРЕЛЬНЫМИ ПРОНИКАЮЩИМИ ЧЕРЕПНО-МОЗГОВЫМИ РАНЕНИЯМИ
1Сирко А.Г., 1Йовенко И.А., 1Жилюк В.И., 2Мосенцев Н.Ф., 2Пилипенко Г.С.
1Государственное учреждение «Днепропетровская медицинская академия МОЗ Украины»; 2Коммунальное учреждение 
«Днепропетровская областная клиническая больница им. И.И. Мечникова», Украина
вещества головного мозга – 1 случай. Инфекции у пациен-
тов с боевыми черепно-мозговыми ранениями в большин-
стве случаев следует рассматривать как нозокомиальные, 
связанныхес медицинскими процедурами и устройствами. 
Терапия антибиотиками первого выбора (ACCESS) в 
большинстве случаев оказалась неэффективной, часто 
возникала необходимость назначения антибактериаль-
ных препаратов широкого спектра действия, в том числе 
антибиотиков второго выбора (WATCH) и препаратов ре-
зерва (RESERVE) по классификации ВОЗ. В результате 
проведенного исследования доказано преимущество ис-
пользования стартовой эмпирической деэскалационной 
антибактериальной терапии препаратами максимально 
широкого спектра действия в режиме комбинированной 
терапии грам-положительных и грам-отрицательных аэ-
робных и анаэробных возбудителей инфекций.
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Cirqovan-septikuri garTulebebis antibaqteriuli Terapia pacientebSi sabrZolo cecxlnasroli 
gamWoli qala-tvinis WrilobebiT 
1a.sirko, 1i.iovenko, 1v.Jiliuki, 2n.mosencevi, 2g.pilipenko 
1saxelmwifo dawesebuleba „ukrainis jandacvis saministros dnepropetrovskis samedicino akademia“; 
2i. meCnikovis sax. dnepropetrovskis saolqo klinikuri saavadmyofo, ukraina
kvlevis mizans warmoadgenda infeqciebis 
gamomwvevebis da maTi antibaqteriuli Terapiis 
mimarT mgrZnobelobis analizi dazaralebuleb-
Si cecxlnasroli gamWoli qala-tvinis Wrilo-
bebiT, rekomendaciebis SemuSaveba travmis Semd-
gomi meningoencefalitis mkurnalobis Taobaze.
gaanalizebulia 121 sabrZolo cecxlnasro-
li gamWoli qala-tvinis WrilobebiT dazara-
lebulis mkurnaloaba i. meCnikovis saxelobis 
dnepropetrovskis saolqo klinikuri saavadmyo-
foSi, 2014  wlis 25 maisidan 2017  wlis 31 de-
kembramde. Sidaqalis Cirqovan-septikuri gar-
Tulebebi gamouvlinda 14  (11,6%) daWrils: 
izolirebuli meningoencefaliti – 8 SemTxveva, 
meningoencefaliti ventrikulitTan erTad – 3 
SemTxveva, meningoencefaliti ventrikulitTan da 
subduralur empiemasTan erTad – 2 SemTxveva, Ta-
vis tvinis nivTierebis mravlobiTi abscedireba 
– 1 SemTxveva.
infeqciebi dazaralebulebSi sabrZolo ce-
cxlnasroli qala-tvinis WrilobebiT umetes 
SemTxvevaSi unda ganvixiloT, rogorc nozoko-
mialuri, romlebic dakavSirebulia samedicino 
procedurebsa da mowyobilobebTan. Terapia 
pirveladi SerCevis antibiotikebiT (ACCESS) 
umetes SemTxvevaSi ar iyo efeqturi, xSirad 
aucilebeli xdeboda moqmedebis farTo speqtris 
mqone antibaqteriuli preparatebis daniSvna, maT 
Soris, romlebic ganekuTvneba meore SerCevis an-
tibiotikebs (WATCH) da rezervis preparatebs 
(RESERVE), msoflio jandacvis organizaciis 
klasifikaciis Tanaxmad. CvenebaSia sastarto 
empiriuli deeskalaciuri antibaqteriuli Tera-
piis gamoyeneba moqmedebis maqsimalurad farTo 
speqtris preparatebiT, upiratesad, kombinire-
buli Terapiis reJimSi savaraudo gram-dadebiTi 
da gram-uaryofiTi aerobuli da anaerobuli in-
feqciebis gamomwvevebis mimarTulebiT.
